UGUK17036 / Fung RCC Carevive Pilot IIT / Chunkit Fung
Research Question:
Will a computer-based method of at-home symptom reporting and management be feasible
to implement among patients with metastatic renal cell carcinoma (RCC)?
Basic Study Information
Purpose:
To determine if Carevive software, which monitors treatment-related toxicities and
then generates self-care management plans for these symptoms, will be feasible to
implement among patients with metastatic renal cell carcinoma (RCC). Additionally
for collection of preliminary data on treatment-related toxicities, quality of life,
distress level, and drug adherence.
Location: University of Rochester Medical Center
Study Reference #: UGUK17036
Lead Researcher (Principal Investigator)
Lead Researcher:
Chunkit Fung
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Learn More About These Conditions
More information about Carcinoma, Renal Cell
More information about Kidney Cancer
Trial Not Found
The study you are looking for is not active at this time.
Return to Search